Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05905575 · ClinicalTrials.gov registry record · Phase 1
A Family Dyad-focused Diabetes Self-Management Intervention for African American Adults
A Phase 1 study of Diabetes Mellitus, Type 2, sponsored by Ohio State University.
- Active
- Registry status
- Phase 1
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT05905575 is a Phase 1 study of Diabetes Mellitus, Type 2 that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 208 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05905575, a Phase 1 study of Diabetes Mellitus, Type 2, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
A family dyad-focused diabetes self-management for African American adults with type 2 diabetes is a randomized controlled trial (RCT) that aims to test the feasibility, acceptability, and efficacy of a family-dyad focused intervention on glycemic control (hemoglobin A1c) and health-related quality of life (HRQOL) in African American adults with type 2 diabetes (T2D).
Conditions Studied
Interventions
- BEHAVIORAL Family dyad diabetes intervention
Study Locations (1)
Ohio
- The Ohio State University College of Nursing - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2027-01-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05905575
The ClinicalTrials.gov registry entry for NCT05905575 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (95% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Family dyad diabetes intervention is the first listed.
NCT05905575 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05905575 about?
NCT05905575 is a clinical study titled "A Family Dyad-focused Diabetes Self-Management Intervention for African American Adults". A family dyad-focused diabetes self-management for African American adults with type 2 diabetes is a randomized controlled trial (RCT) that aims to test the feasibility, acceptability, and efficacy of a family-dyad focused intervention on glycemic control (hemoglobin A1c) and health-related quality ...
What is the current status of trial NCT05905575?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 208 participants. The study started on 2023-06-01. Estimated completion is 2027-01-31.
What conditions does trial NCT05905575 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT05905575?
The interventions under investigation include: Family dyad diabetes intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05905575?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05905575 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
RECRUITING · Phase 1
-
Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)
RECRUITING · Phase 1
-
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
ACTIVE NOT RECRUITING · Phase 1
-
Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes
ACTIVE NOT RECRUITING · Phase 1
-
Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects
COMPLETED · Phase 1
-
Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.